Class action lawsuits against genetic testing companies over PGT-A
By Ruth Retassie,
PET
| 10. 21. 2024
Former IVF patients in the USA have filed class action lawsuits against several companies for misleading them about the efficacy of PGT-A.
Class action lawsuits have been filed against CooperGenomics, CooperSurgical, The Cooper Companies, Reproductive Genetic Innovations, Progenesis, and Natera by former patients to recuperate funds spent on preimplantation genetic testing for aneuploidy (PGT-A). The lawsuits allege that these companies engaged in consumer fraud and breach of warranty by selling PGT-A to IVF patients, without disclaiming that this test is unproven, experimental, and entails risks of both misdiagnosis and embryo damage during the biopsy. The plaintiffs and class action members claim they would not have purchased testing if given accurate information about its efficacy.
Paula Bliss, partner and co-founder of Justice Law Collaborative and counsel for the plaintiffs, said: 'Our clients have been forced to make consequential decisions based on PGT-A testing that was falsely marketed as having unproven benefits... we seek justice on their behalf.'
PGT-A is conducted to analyse the chromosomal makeup of embryos. The aim is to improve chances of a live birth...
Related Articles
By Anumita Kaur [cites CGS’ Katie Hasson], The Washington Post | 03.25.2025
Genetic information company 23andMe has said that it is headed to bankruptcy court, raising questions for what happens to the DNA shared by millions of people with the company via saliva test kits.
Sunday’s announcement clears the way for a new...
By Peter Wehling, Tino Plümecke, and Isabelle Bartram
| 03.26.2025
This article was originally published as “Soziogenomik und polygene Scores” in issue 272 (February 2025) of the German-language journal Gen-ethischer Informationsdienst (GID); translated by the authors.
In mid-November 2024, the British organization Hope not Hate published its investigative research ‘Inside the Eugenics Revival’. In addition to documentating an active international “race research” network, the investigation also brought to light the existence of a US start-up that offers eugenic embryo selection. Heliospect Genomics aims to enable wealthy couples to...
By Frank Landymore, Futurism | 03.18.2025
You can only throw so much money at a problem.
This, more or less, is the line being taken by AI researchers in a recent survey. Asked whether "scaling up" current AI approaches could lead to achieving artificial general...
By Craig S. Smith, Forbes | 03.08.2025
One recent evening in Shenzhen, a group of software engineers gathered in a dimly lit co-working space, furiously typing as they monitored the performance of a new AI system. The air was electric, thick with the hum of servers and...
